Use access key #2 to skip to page content.
$4.77 0.46 (10.67%)
7/8/2008 4:00 PM

Dendreon Corp (DNDN)

CAPS Rating:
**

A biotechnology company focused on the discovery, development and commercialization of novel therapeutics that harness the immune system to fight cancer.

View All Commentary (DNDN)

Recs

0

Avatar p50 (56.56) Submitted: 5/13/08 12:09 AM : Outperform Start Price: $5.12 DNDN Score: 2.57

to take the DNDN bet or not? FDA approval will make or break this stock!

Report this Post Replies: 0 | Reply

Featured Broker Partners